What is Sterisil?
Operating under the Solmetex umbrella, Sterisil provides essential infrastructure for dental practices, focusing on waterline management and regulatory compliance. Since its inception, the organization has established itself as a leader in dental water quality, addressing complex challenges such as amalgam capture and environmental sustainability. By integrating advanced filtration and treatment technologies, Sterisil enables dental offices to maintain rigorous safety standards while minimizing their ecological footprint. The company serves as a cornerstone of the broader Solmetex portfolio, which includes DryShield, collectively offering a comprehensive suite of solutions for modern dental operations.
How much funding has Sterisil raised?
Sterisil has raised a total of $1M across 2 funding rounds:
Debt
$350K
Debt
$660K
Debt (2020): $350K with participation from PPP
Debt (2021): $660K led by PPP
Key Investors in Sterisil
PPP
Public-Private Partnership
What's next for Sterisil?
With this major strategic investment, Sterisil is positioned to accelerate its operational scaling and enhance its technological capabilities. The capital will likely be deployed to expand the company's reach within the dental market, potentially through increased R&D in water purification systems and the strengthening of its compliance-focused service offerings. As environmental regulations for medical facilities tighten, Sterisil's role in providing reliable, automated water management solutions becomes increasingly vital. The firm is expected to leverage this financial backing to solidify its competitive advantage and drive long-term growth in the dental infrastructure space.
See full Sterisil company page
